Search research articles
Contact Us
Filters
Showing results (291-300 of 302) with videos related to
Page
of 31
Sort By:
Cancer Research
|
February 15, 1996
A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma
S C Righetti, G Della Torre, S Pilotti, et al.
Oral Oncology
|
September 23, 2008
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study
L D Locati, P Bossi, F Perrone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 6, 2013
Phase II study on lapatinib in advanced EGFR-positive chordoma
S Stacchiotti, E Tamborini, S Lo Vullo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 7, 2011
Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma
A Gronchi, B N Bui, S Bonvalot, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 8, 2014
Activity of sunitinib in extraskeletal myxoid chondrosarcoma
S Stacchiotti, M A Pantaleo, A Astolfi, et al.
The American Journal of Pathology
|
September 15, 1998
ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum
B Falini, B Bigerna, M Fizzotti, et al.
Cancer Research
|
June 1, 1997
Association between cigarette smoking and FHIT gene alterations in lung cancer
G Sozzi, L Sard, L De Gregorio, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 9, 2016
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact
L D Locati, F Perrone, B Cortelazzi, et al.
Oncogene
|
November 12, 2013
Mode of action of trabectedin in myxoid liposarcomas
S Di Giandomenico, R Frapolli, E Bello, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 2, 2014
Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour
S Stacchiotti, M Tortoreto, G G Baldi, et al.
Page
of 31
Search research articles
Search
Showing results (291-300 of 302) with videos related to
Sort By:
Page
of 31
Cancer Research
|
February 15, 1996
A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma
S C Righetti, G Della Torre, S Pilotti, et al.
Oral Oncology
|
September 23, 2008
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study
L D Locati, P Bossi, F Perrone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 6, 2013
Phase II study on lapatinib in advanced EGFR-positive chordoma
S Stacchiotti, E Tamborini, S Lo Vullo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 7, 2011
Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma
A Gronchi, B N Bui, S Bonvalot, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 8, 2014
Activity of sunitinib in extraskeletal myxoid chondrosarcoma
S Stacchiotti, M A Pantaleo, A Astolfi, et al.
The American Journal of Pathology
|
September 15, 1998
ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum
B Falini, B Bigerna, M Fizzotti, et al.
Cancer Research
|
June 1, 1997
Association between cigarette smoking and FHIT gene alterations in lung cancer
G Sozzi, L Sard, L De Gregorio, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 9, 2016
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact
L D Locati, F Perrone, B Cortelazzi, et al.
Oncogene
|
November 12, 2013
Mode of action of trabectedin in myxoid liposarcomas
S Di Giandomenico, R Frapolli, E Bello, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 2, 2014
Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour
S Stacchiotti, M Tortoreto, G G Baldi, et al.
Page
of 31